Revenue
3.2 million USD
2027 Q2 · USD
Exact inputs and evidence
- Revenue: 3200603 USD Source
Annual consolidated revenue for 2026: about USD 9.729M, using the latest reported figures. The previous period, 2025, was about USD 9.114M.
3.2 million USD
2027 Q2 · USD
6.33%
2027 Q2 · %
108 thousand USD
2027 Q2 · USD
60.9 thousand USD
2027 Q2 · USD
11755548 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
10.2 million USD
2025-09-01 – 2026-08-31
597 thousand USD
2025-09-01 – 2026-08-31
374 thousand USD
2025-09-01 – 2026-08-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-08.
Financial data available through: 2026-02-28.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 9.11 million
–
Current period
USD 9.73 million
–
9729463 − 9113607 = 615856 USD
9113607 USD · 2024-03-01 – 2025-02-28
Inspect prior input Prior source9729463 USD · 2025-03-01 – 2026-02-28
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 2.16 million
–
Current period
USD 794,502
–
794502 − 2159473 = -1364971 USD
2159473 USD · 2024-03-01 – 2025-02-28
Inspect prior input Prior source794502 USD · 2025-03-01 – 2026-02-28
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 877,834
–
Current period
USD 906,798
–
906798 − 877834 = 28964 USD
877834 USD · 2024-03-01 – 2025-02-28
Inspect prior input Prior source906798 USD · 2025-03-01 – 2026-02-28
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 89,013
–
Current period
USD 1,363
–
1363 − 89013 = -87650 USD
89013 USD · 2024-03-01 – 2025-02-28
Inspect prior input Prior source1363 USD · 2025-03-01 – 2026-02-28
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2022-03-01 – 2023-02-28 | 999579 | 1238166 Derived | -238587 | 114148 Derived | -352735 | -545826 Derived | Source
|
| 2024 2023-03-01 – 2024-02-29 | 5020391 | 4419813 Derived | 600578 | 1005266 Derived | -404688 | Unavailable | Source
|
| 2025 2024-03-01 – 2025-02-28 | 9113607 | 5922108 Derived | 3191499 | 1032026 Derived | 2159473 | 788821 Derived | Source
|
| 2026 2025-03-01 – 2026-02-28 | 9729463 | 8634951 Derived | 1094512 | 300010 Derived | 794502 | 905435 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 999579 |
|
| 2024 | Revenue | 5020391 |
|
| 2025 | Revenue | 9113607 |
|
| 2026 | Revenue | 9729463 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 402.3% |
|
| 2025 | Year over year | 81.5% |
|
| 2026 | Year over year | 6.8% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -23.9% |
|
| 2024 | Operating margin | 12% |
|
| 2025 | Operating margin | 35% |
|
| 2026 | Operating margin | 11.2% |
|
| 2023 | Net margin | -35.3% |
|
| 2024 | Net margin | -8.1% |
|
| 2025 | Net margin | 23.7% |
|
| 2026 | Net margin | 8.2% |
|
| 2023 | Free cash flow margin | -54.6% |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | 8.7% |
|
| 2026 | Free cash flow margin | 9.3% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -490549 |
|
| 2024 | Operating cash flow | 14242 |
|
| 2025 | Operating cash flow | 877834 |
|
| 2026 | Operating cash flow | 906798 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -545826 |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | 788821 |
|
| 2026 | Free cash flow | 905435 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Liabilities / assets | 43.1% |
|
| 2024 | Liabilities / assets | 54.9% |
|
| 2025 | Liabilities / assets | 37.3% |
|
| 2026 | Liabilities / assets | 16.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Current assets / current liabilities | 47.25× |
|
| 2024 | Current assets / current liabilities | 5.29× |
|
| 2025 | Current assets / current liabilities | 4.27× |
|
| 2026 | Current assets / current liabilities | 5.83× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2022-03-01 – 2023-02-28 | −USD 352,735 Exact valueExact value: -352735 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 490,549 Exact valueExact value: -490549 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 55,277 Exact valueExact value: 55277 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 545,826 Calculation and evidence-490549 − 55277 USD Exact free cash flow: -545826 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-03-01 – 2024-02-29 | −USD 404,688 Exact valueExact value: -404688 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 14,242 Exact valueExact value: 14242 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable The mapped spending value is negative, so its direction is unclear. | Unavailable Capital expenditure has a negative mapped value; spending direction is unclear. |
| 2025 2024-03-01 – 2025-02-28 | USD 2.16 million Exact valueExact value: 2159473 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 877,834 Exact valueExact value: 877834 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 89,013 Exact valueExact value: 89013 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 788,821 Calculation and evidence877834 − 89013 USD Exact free cash flow: 788821 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-03-01 – 2026-02-28 | USD 794,502 Exact valueExact value: 794502 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 906,798 Exact valueExact value: 906798 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1,363 Exact valueExact value: 1363 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 905,435 Calculation and evidence906798 − 1363 USD Exact free cash flow: 905435 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
18 filings · 2,058 latest values · 2,058 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001931055, 1931055, MDNC, edgar:1931055
Also known as MEDINOTEC, INC., Medinotec Inc., Medinotec, Inc.